Chien‐Hung Chen

8.2k total citations
233 papers, 5.6k citations indexed

About

Chien‐Hung Chen is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Chien‐Hung Chen has authored 233 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 202 papers in Epidemiology, 202 papers in Hepatology and 17 papers in Infectious Diseases. Recurrent topics in Chien‐Hung Chen's work include Liver Disease Diagnosis and Treatment (158 papers), Hepatitis C virus research (151 papers) and Hepatitis B Virus Studies (146 papers). Chien‐Hung Chen is often cited by papers focused on Liver Disease Diagnosis and Treatment (158 papers), Hepatitis C virus research (151 papers) and Hepatitis B Virus Studies (146 papers). Chien‐Hung Chen collaborates with scholars based in Taiwan, United States and Germany. Chien‐Hung Chen's co-authors include Jing‐Houng Wang, Tsung‐Hui Hu, Sheng‐Nan Lu, Chuan–Mo Lee, Chao‐Hung Hung, Chi‐Sin Changchien, Chao‐Hung Hung, Kwong‐Ming Kee, Jin‐Chuan Sheu and Yi‐Hao Yen and has published in prestigious journals such as ACS Nano, Gastroenterology and PLoS ONE.

In The Last Decade

Chien‐Hung Chen

227 papers receiving 5.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chien‐Hung Chen Taiwan	41	4.4k	4.2k	532	488	390	233	5.6k
Jee‐Fu Huang Taiwan	38	4.0k 0.9×	3.9k 0.9×	425 0.8×	432 0.9×	291 0.7×	290	5.4k
William Sievert Australia	35	4.8k 1.1×	4.6k 1.1×	574 1.1×	771 1.6×	280 0.7×	154	6.5k
Hiroshi Yatsuhashi Japan	38	2.9k 0.7×	3.0k 0.7×	506 1.0×	500 1.0×	338 0.9×	185	4.4k
Hyung Joon Yim South Korea	33	2.8k 0.7×	3.1k 0.7×	400 0.8×	1.1k 2.3×	305 0.8×	243	4.7k
Antonina Smedile Italy	41	6.7k 1.5×	6.6k 1.6×	502 0.9×	584 1.2×	303 0.8×	199	8.1k
Margaret F. Bassendine United Kingdom	44	4.8k 1.1×	5.6k 1.3×	569 1.1×	987 2.0×	452 1.2×	120	7.4k
Chuan–Mo Lee Taiwan	40	4.3k 1.0×	4.3k 1.0×	481 0.9×	780 1.6×	396 1.0×	122	5.9k
Dominique Roulot France	34	3.6k 0.8×	3.6k 0.9×	501 0.9×	825 1.7×	240 0.6×	112	4.9k
John Koskinas Greece	32	2.0k 0.4×	2.1k 0.5×	417 0.8×	467 1.0×	314 0.8×	140	3.5k
Jaw‐Ching Wu Taiwan	38	3.0k 0.7×	3.3k 0.8×	370 0.7×	549 1.1×	456 1.2×	145	4.9k

Countries citing papers authored by Chien‐Hung Chen

Since Specialization

Citations

This map shows the geographic impact of Chien‐Hung Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien‐Hung Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien‐Hung Chen more than expected).

Fields of papers citing papers by Chien‐Hung Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien‐Hung Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien‐Hung Chen. The network helps show where Chien‐Hung Chen may publish in the future.

Co-authorship network of co-authors of Chien‐Hung Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Chien‐Hung Chen. A scholar is included among the top collaborators of Chien‐Hung Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chien‐Hung Chen. Chien‐Hung Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yen, Yi‐Hao, Sheng‐Nan Lu, Tsung‐Hui Hu, et al.. (2025). Survival outcome with liver resection versus percutaneous radiofrequency ablation in patients with 2–3 cm single hepatocellular carcinoma. Asian Journal of Surgery. 48(11). 6691–6698.

Yong, Chee‐Chien, Kwong‐Ming Kee, Sheng‐Nan Lu, et al.. (2025). Overall survival is comparable between percutaneous radiofrequency ablation and liver resection as first-line therapies for solitary 3–5 cm hepatocellular carcinoma. Langenbeck s Archives of Surgery. 410(1). 66–66. 1 indexed citations

Huang, Pao‐Yuan, Yu‐Cheng Lin, Chih‐Chi Wang, & Chien‐Hung Chen. (2024). Clinical outcomes and predictors in patients with acute on chronic liver failure in Southern Taiwan. Journal of the Formosan Medical Association. 124(3). 234–240.

Lin, Yen‐Po, Yu‐Chieh Tsai, Pao‐Yuan Huang, et al.. (2024). Effect of gut microbiota and PNPLA3 polymorphisms on nonalcoholic fatty liver disease in lean and obese individuals. Advances in digestive medicine. 11(3). 129–139. 1 indexed citations

Tai, Wei‐Chen, Chih‐Ming Liang, Cheng‐Kun Wu, et al.. (2024). Alternations of the gut microbiota and the Firmicutes/Bacteroidetes ratio after biologic treatment in inflammatory bowel disease. Journal of Microbiology Immunology and Infection. 58(1). 62–69. 37 indexed citations

Hsiao, Ya‐Wen, Jing‐Houng Wang, Yen‐Hao Chen, et al.. (2023). Well‐controlled viremia reduces the progression of hepatocellular carcinoma in chronic viral hepatitis patients treated with lenvatinib. The Kaohsiung Journal of Medical Sciences. 39(12). 1233–1242. 1 indexed citations

Yao, Chih‐Chien, Jing‐Houng Wang, Chien‐Hung Chen, et al.. (2023). Short Half-Life of Des-γ-Carboxy Prothrombin Is a Superior Factor for Early Prediction of Outcomes of Hepatocellular Carcinoma Treated with Radiofrequency Ablation. Diagnostics. 13(4). 696–696. 2 indexed citations

Jeng, Wen‐Juei, Tsung‐Hui Hu, Jing‐Houng Wang, et al.. (2022). Combined baseline HBcrAg and end-of-treatment HBsAg predict HBV relapse after entecavir or tenofovir cessation. Journal of Antimicrobial Chemotherapy. 78(2). 436–439. 2 indexed citations

Hu, Tsung‐Hui, Sherry Yueh‐Hsia Chiu, Po‐Lin Tseng, et al.. (2020). Five‐year comparative risk of hepatocellular carcinoma development under entecavir or tenofovir treatment‐naïve patients with chronic hepatitis B‐related compensated cirrhosis in Taiwan. Alimentary Pharmacology & Therapeutics. 52(11-12). 1695–1706. 14 indexed citations

10.

Tsai, Ming‐Chao, Yu-Yin Liu, Chih‐Che Lin, et al.. (2020). Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan. Nutrients. 12(3). 820–820. 70 indexed citations

11.

Tsai, Ming‐Chao, Chun‐Yen Lin, Chien‐Hung Chen, et al.. (2020). Serial changes of renal function after directly acting antivirals treatment for chronic hepatitis C: A 1-year follow-up study after treatment. PLoS ONE. 15(4). e0231102–e0231102. 11 indexed citations

12.

Huang, Pao‐Yuan, Chih‐Chi Wang, Chih‐Che Lin, et al.. (2019). Predictive Effects of Inflammatory Scores in Patients with BCLC 0-A Hepatocellular Carcinoma after Hepatectomy. Journal of Clinical Medicine. 8(10). 1676–1676. 24 indexed citations

13.

Yen, Yi‐Hao, Fang‐Ying Kuo, Kwong‐Ming Kee, et al.. (2018). Diabetes is associated with advanced fibrosis and fibrosis progression in non-genotype 3 chronic hepatitis C patients. Digestive and Liver Disease. 51(1). 142–148. 2 indexed citations

14.

Yen, Yi‐Hao, Ming‐Tsung Lin, Fang‐Ying Kuo, et al.. (2017). The association between steatosis and diabetes with hepatocellular carcinoma in non‐genotype 3 chronic hepatitis C patients. Liver International. 38(6). 1064–1073. 14 indexed citations

15.

Hu, Tsung‐Hui, Kuo‐Chin Chang, Po‐Lin Tseng, et al.. (2017). Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy. Medicine. 96(46). e8696–e8696. 9 indexed citations

16.

Wu, Cheng‐Kun, Kuo‐Chin Chang, Chao‐Hung Hung, et al.. (2016). Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy. Journal of Antimicrobial Chemotherapy. 71(7). 1943–1947. 20 indexed citations

17.

Lee, Chuan–Mo, Chao‐Hung Hung, Jing‐Houng Wang, et al.. (2014). High Risk of Hepatitis B Virus Reactivation in Nucleos(t)ide Analogue-Induced Hepatitis B e Antigen Seroconverters Older Than 40 Years. Digestive Diseases and Sciences. 59(10). 2580–2587. 8 indexed citations

18.

Kuo, Yuan‐Hung, Chien‐Hung Chen, Jing‐Houng Wang, et al.. (2009). Extended lamivudine consolidation therapy in hepatitis B e antigen-positive chronic hepatitis B patients improves sustained hepatitis B e antigen seroconversion. Scandinavian Journal of Gastroenterology. 45(1). 75–81. 31 indexed citations

19.

Hung, Chien‐Hui, Chien‐Hung Chen, C.‐M. Lee, et al.. (2007). Association of amino acid variations in the NS5A and E2‐PePHD region of hepatitis C virus 1b with hepatocellular carcinoma. Journal of Viral Hepatitis. 15(1). 58–65. 23 indexed citations

20.

Chen, Chien‐Hung, Guan‐Tarn Huang, Pei–Ming Yang, et al.. (2006). Hepatitis B- and C-related hepatocellular carcinomas yield different clinical features and prognosis. European Journal of Cancer. 42(15). 2524–2529. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact